SIMCERE PHARMACEUTICAL GROUP Interest Costs Incurred
SIMCERE PHARMACEUTICAL GROUP reported Interest Costs Incurred of CNY 70.93 million for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InterestCostsIncurred · last filed 2013-04-26
CNY
| Period end | Interest Costs Incurred 12 month |
|---|---|
| 2012-12-31 | 70.93M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | 45.08M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 24.39M CNY 20-F · filed 2013-04-26 |
USD
| Period end | Interest Costs Incurred 12 month |
|---|---|
| 2012-12-31 | $11.38M 20-F · filed 2013-04-26 |